$SGNT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sagent Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sagent Pharmaceuticals, Inc.. Get notifications about new insider transactions in Sagent Pharmaceuticals, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 22.07 | 76,700 | 1,692,769 | 2,779,003 | 2.9 M to 2.8 M (-2.69 %) |
| Feb 17 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 21.93 | 10,000 | 219,300 | 2,855,703 | 2.9 M to 2.9 M (-0.35 %) |
| Feb 17 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 22.34 | 300 | 6,702 | 2,865,703 | 2.9 M to 2.9 M (-0.01 %) |
| Feb 06 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 22.79 | 10,000 | 227,900 | 2,866,003 | 2.9 M to 2.9 M (-0.35 %) |
| Feb 06 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 22.31 | 13,514 | 301,497 | 2,876,003 | 2.9 M to 2.9 M (-0.47 %) |
| Feb 06 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 22.30 | 12,837 | 286,265 | 2,889,517 | 2.9 M to 2.9 M (-0.44 %) |
| Feb 01 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 22.27 | 45,000 | 1,002,150 | 2,902,354 | 2.9 M to 2.9 M (-1.53 %) |
| Feb 01 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 22.19 | 3,398 | 75,402 | 2,947,354 | 3 M to 2.9 M (-0.12 %) |
| Feb 01 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 22.13 | 1,702 | 37,665 | 2,950,752 | 3 M to 3 M (-0.06 %) |
| Jan 27 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 22.43 | 5,538 | 124,217 | 2,952,454 | 3 M to 3 M (-0.19 %) |
| Jan 27 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 22.46 | 4,838 | 108,661 | 2,957,992 | 3 M to 3 M (-0.16 %) |
| Jan 27 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 22.53 | 15,000 | 337,950 | 2,962,830 | 3 M to 3 M (-0.50 %) |
| Jan 24 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 22.16 | 19,844 | 439,743 | 2,977,830 | 3 M to 3 M (-0.66 %) |
| Jan 19 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 21.86 | 18,000 | 393,480 | 2,997,674 | 3 M to 3 M (-0.60 %) |
| Jan 19 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 21.91 | 24,900 | 545,559 | 3,015,674 | 3 M to 3 M (-0.82 %) |
| Jan 19 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 21.95 | 3,041 | 66,750 | 3,040,574 | 3 M to 3 M (-0.10 %) |
| Jan 13 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 21.89 | 87,385 | 1,912,858 | 3,043,615 | 3.1 M to 3 M (-2.79 %) |
| Jan 13 2012 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Sell | S | 21.91 | 8,700 | 190,617 | 3,131,000 | 3.1 M to 3.1 M (-0.28 %) |
| Nov 23 2011 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | P | 20.18 | 1,000 | 20,180 | 3,000 | 2 K to 3 K (+50.00 %) |
| Sep 20 2011 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | Chief Financial Off ... | Option Exercise | A | 20.10 | 55,000 | 1,105,500 | 55,000 | |
| Aug 17 2011 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | P | 19.75 | 1,000 | 19,750 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Aug 17 2011 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | P | 19.95 | 1,000 | 19,950 | 1,000 | 0 to 1,000 |
| Apr 28 2011 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Option Exercise | C | 0.00 | 21,428,571 | 0 | 0 | |
| Apr 28 2011 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Option Exercise | X | 5,000,000.00 | 1 | 5,000,000 | 0 | |
| Apr 28 2011 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Option Exercise | X | 1,420.00 | 1 | 1,420 | 0 | |
| Apr 28 2011 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Buy | C | 0.00 | 2,734,000 | 0 | 3,188,500 | 454.5 K to 3.2 M (+601.54 %) |
| Apr 28 2011 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Buy | X | 16.00 | 312,500 | 5,000,000 | 454,500 | 142 K to 454.5 K (+220.07 %) |
| Apr 28 2011 | SGNT | Sagent Pharmaceuti ... | China Renaissance Capital Inve ... | 10% Owner | Buy | X | 0.01 | 142,000 | 1,420 | 142,000 | 0 to 142 K |
| Apr 25 2011 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Buy | P | 16.00 | 20,000 | 320,000 | 26,379 | 6.4 K to 26.4 K (+313.53 %) |
| Apr 25 2011 | SGNT | Sagent Pharmaceuti ... | Yu Chen-Ming | Director | Buy | P | 16.00 | 1,000 | 16,000 | 1,000 | 0 to 1,000 |
| Apr 20 2011 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Buy | P | 16.00 | 1,000 | 16,000 | 1,000 | 0 to 1,000 |